Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03499314 · ClinicalTrials.gov registry record · NA
A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03499314 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 65 participants.
The verdict
NCT03499314, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
This is a randomized, double-blind pilot clinical trial to test a novel treatment approach to rehabilitate fine motor function in individuals living with progressive multiple sclerosis (MS) using anodal transcranial direct current stimulation (tDCS) to augment manual dexterity training. Treatment will be delivered to individuals at home using a state-of-the-art remotely supervised tele-rehabilitation protocol, a major advantage for patients with respect to ease of access, feasibility, reinforcement learning and minimal burden of in clinic study visit participation. Improvements in fine motor skill will be assessed at each remote session using a novel portable grip device that measures execution and adaptation or learning of fingertip forces during grasp, which is more sensitive than standard measures of hand function.
Interventions
- DEVICE Active RS-tDCS +At-Home Manual Dexterity Training
- DEVICE Sham RS-tDCS +At-Home Manual Dexterity Training
- OTHER Manual dexterity training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2018-04-15 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03499314
The ClinicalTrials.gov registry entry for NCT03499314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Active RS-tDCS +At-Home Manual Dexterity Training is the first listed.
NCT03499314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03499314 about?
NCT03499314 is a clinical study titled "A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)". This is a randomized, double-blind pilot clinical trial to test a novel treatment approach to rehabilitate fine motor function in individuals living with progressive multiple sclerosis (MS) using anodal transcranial direct current stimulation (tDCS) to augment manual dexterity training. Treatment wi...
What is the current status of trial NCT03499314?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2018-04-15. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT03499314?
The interventions under investigation include: Active RS-tDCS +At-Home Manual Dexterity Training (DEVICE), Sham RS-tDCS +At-Home Manual Dexterity Training (DEVICE), Manual dexterity training (OTHER).
Who is sponsoring clinical trial NCT03499314?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.